Jarl E Strange
Overview
Explore the profile of Jarl E Strange including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abassi N, Nouhravesh N, Elmegaard M, Austreim M, Zahir D, Garred C, et al.
J Am Heart Assoc
. 2025 Feb;
14(3):e037973.
PMID: 39895527
Background: Heart failure (HF) and frailty often coexist. However, it is unknown how the interplay between HF and frailty at HF onset impacts prognosis of frail patients with HF and...
2.
Vistisen H, Graversen P, Havers-Borgersen E, Strange J, Ostergaard L, Butt J, et al.
Eur Heart J Qual Care Clin Outcomes
. 2025 Jan;
PMID: 39890602
Background: Antithrombotic therapy post-transcatheter aortic valve implantation (TAVI) has been widely debated in the past two decades. Data describing practice patterns of antithrombotic therapy are warranted. This study examined the...
3.
Lundberg S, Knigge P, Strange J, Nouhravesh N, Wagner A, Malik M, et al.
Am Heart J
. 2024 Aug;
278:83-92.
PMID: 39216691
Background: Despite improved survival, hospitalization is still common among patients with heart failure (HF). Objective: This study aimed to examine temporal trends in infection-related hospitalization among HF patients and compare...
4.
Holt A, Strange J, Rasmussen P, Nouhravesh N, Nielsen S, Sindet-Pedersen C, et al.
J Am Coll Cardiol
. 2024 May;
83(19):1870-1882.
PMID: 38719367
Background: Incrementing numbers of patients treated for attention-deficit/hyperactivity disorder (ADHD) call for scrutiny concerning long-term drug-safety. Objectives: This study aims to investigate associations between long-term use of ADHD treatment and...
5.
Nielsen S, Lamberts M, Nouhravesh N, Jensen M, Strange J, Gislason G, et al.
Int J Cardiol
. 2024 May;
408:132137.
PMID: 38705205
Background: Limited knowledge of antihypertensive treatment of the elderly potentially impedes effective strategies for hypertension management in this growing patient group. We aimed to investigate temporal trends for first-line drug...
6.
Zahir Anjum D, Strange J, Fosbol E, Garred C, Elmegaard M, Andersson C, et al.
Eur J Heart Fail
. 2024 May;
26(8):1717-1726.
PMID: 38700461
Aims: Although recent randomized clinical trials have demonstrated the advantages of heart failure (HF) therapy in both frail and not frail patients, there is insufficient information on the use of...
7.
Madsen O, Lamberts M, Olesen J, Hansen M, Kumler T, Grove E, et al.
Int J Cardiol
. 2024 Apr;
408:132098.
PMID: 38679168
Background: Percutaneous left atrial appendage occlusion (LAAO) is increasingly used for stroke prevention in patients with atrial fibrillation and anticoagulant-related complications. Yet, real-life studies evaluating changes in patient characteristics and...
8.
Nouhravesh N, Strange J, Sindet-Pedersen C, Holt A, Tonnesen J, Andersen C, et al.
Int J Cardiol
. 2024 Apr;
406:132001.
PMID: 38561107
Background: Pulmonary embolism (PE) is described as a prognostic factor in patients with cancer however, the prognostic impact of PE remains unknown. This study investigated, the 1-year prognosis following PE...
9.
Knigge P, Lundberg S, Strange J, Malik M, Nouhravesh N, Wagner A, et al.
J Am Heart Assoc
. 2024 Mar;
13(6):e032539.
PMID: 38471834
Background: The incidence and distribution of acute and chronic dialysis among patients with heart failure (HF), stratified by diabetes, remain uncertain. We hypothesized that with improved survival and rising comorbidities,...
10.
Holt A, Nouhravesh N, Strange J, Nielsen S, Schjerning A, Rasmussen P, et al.
Eur Heart J
. 2024 Jan;
45(6):475-484.
PMID: 38200679
Background And Aims: A rising number of countries allow physicians to treat chronic pain with medical cannabis. However, recreational cannabis use has been linked with cardiovascular side effects, necessitating investigations...